Kamran Khan Selected Research

Isoniazid (Ftivazide)

7/2010	Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB.
11/2008	Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kamran Khan Research Topics

Disease

5	Infections 01/2019 - 01/2007
4	Latent Tuberculosis 01/2019 - 01/2007
4	Neoplasms (Cancer) 12/2016 - 07/2008
3	Asthma (Bronchial Asthma) 01/2021 - 10/2014
2	Out-of-Hospital Cardiac Arrest 01/2021 - 01/2020
2	Heart Arrest (Cardiac Arrest) 01/2021 - 01/2020
2	Dementia (Dementias) 01/2018 - 03/2016
2	Wounds and Injuries (Trauma) 12/2015 - 10/2008
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Leishmaniasis 01/2021
1	Malaria 04/2019
1	Emergence Delirium 01/2019
1	Measles 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Cognitive Dysfunction 01/2018
1	Yellow Fever 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 12/2016
1	Microcephaly 04/2016
1	Cannabinoid Hyperemesis Syndrome 01/2016
1	Osteomyelitis 12/2015
1	Choriocarcinoma 12/2013
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 04/2013
1	Stress Fractures (Stress Fracture) 07/2012
1	Disseminated Intravascular Coagulation 01/2012
1	Asphyxia (Suffocation) 01/2012
1	Shock 01/2012
1	Thyroid Neoplasms (Thyroid Cancer) 12/2011
1	Neoplasm Metastasis (Metastasis) 12/2011
1	Hepatitis 11/2008
1	Medial Tibial Stress Syndrome 10/2008
1	Primary Hyperparathyroidism 07/2008
1	Chronic Hepatitis C 10/2007
1	Body Weight (Weight, Body) 10/2007
1	Hepatitis C 10/2007
1	Fibrosis (Cirrhosis) 10/2007
1	Tuberculosis (Tuberculoses) 01/2007
1	Latent Infection 12/2002

Drug/Important Bio-Agent (IBA)

4	Rifampin (Rifampicin)FDA LinkGeneric 01/2019 - 12/2002
3	Pharmaceutical PreparationsIBA 01/2020 - 03/2016
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 01/2020
2	VaccinesIBA 01/2019 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 07/2010 - 11/2008
2	Tuberculin (PPD)IBA 02/2008 - 01/2007
1	AntioxidantsIBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Tryptamines (Triptans)IBA 01/2021
1	artemisinin (artemisinine)IBA 04/2019
1	montelukast (Singulair)FDA Link 01/2019
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	phenoxyacetic acidIBA 12/2016
1	Agent OrangeIBA 12/2016
1	Amino Acids FDA Link 04/2016
1	AntiemeticsIBA 01/2016
1	Nafcillin FDA LinkGeneric 12/2015
1	MagnesiumIBA 10/2014
1	GoldIBA 04/2013
1	Radioisotopes (Radionuclides)IBA 07/2012
1	IodineIBA 12/2011
1	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 12/2011
1	Ethanol (Ethyl Alcohol)IBA 07/2008
1	Parathyroid Hormone (Parathormone)IBA 07/2008
1	peginterferon alfa-2a (Pegasys)FDA Link 10/2007
1	Antiviral Agents (Antivirals)IBA 10/2007
1	Ribavirin (Virazole)FDA LinkGeneric 10/2007
1	Pyrazinamide FDA LinkGeneric 12/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 10/2007
3	Drug Therapy (Chemotherapy) 12/2015 - 12/2013
2	Length of Stay 01/2019 - 01/2019
2	Radiotherapy 12/2013 - 10/2008
1	Patient Readmission 01/2019
1	Resistance Training 01/2018
1	Activities of Daily Living (ADL) 01/2018
1	Combined Modality Therapy 12/2016
1	Negative-Pressure Wound Therapy 12/2015
1	Electrodes (Electrode) 04/2013
1	Neonatal Intensive Care 01/2012
1	Contraindications 11/2008
1	Splints (Splint) 10/2008
1	Renal Dialysis (Hemodialysis) 01/2007